Louis Philipson

65% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

922 Medicare Part D claims for 99 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 56% of claims.

Most prescribed

1. Mounjaro73 claims
2. Metformin Hcl49 claims
3. Omnipod 5 Dexg7g6 Pods (Gen 5)45 claims
4. Nano 2nd Gen Pen Needle41 claims
5. Humalog40 claims
6. Lantus Solostar39 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The MIPS final score for 2023 (Medicare payment program): 97.7 of 100

The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).

2 hospitals and group practices

1. The University OF Chicago Medical CenterChicago, IL · Acute Care Hospitals4 of 5 stars
2. University OF ChicagoChicago, IL

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through); hospitals matched to CMS Hospital General Information (Care Compare) (data.cms.gov). Star ratings are CMS hospital ratings, not ratings of this provider.